Abstract
Therapeutically delivered mesenchymal stem cells (MSCs) improve ventricular remodeling. However, the mechanism underlying MSC cardiac remodeling has not been clearly determined. Congestive heart failure (CHF) was induced in rats by cauterization of the left ventricular free wall. MSCs were cultured from autologous bone marrow and injected into the border zone and the remote myocardium 5 d after injury. Ten weeks later, when compared with sham operation, CHF significantly increased nucleus mitotic index, capillary density, and expression of insulin-like growth factor 1, hepatocyte growth factor and vascular endothelial growth factor in the border zone (P<0.01) and decreased each of them in the remote myocardium (P<0.05 or P<0.01). MSC implantation in CHF dramatically elevated expression of these growth factors in the remote myocardium and further elevated their expression in the border zone when compared with CHF without MSC addition (P<0.05 or P<0.01). This was paralleled by a higher nucleus mitotic index and a significantly increased capillary density both in the remote myocardium and in the border zone, and by a lower percentage of area of collagen and a higher percentage of area of myocardium in the border zone (P<0.05 or P<0.01), and cardiac remodeling markedly improved. Autologous MSC implantation promoted expression of growth factors in rat failing myocardium, which might enhance cardiomyogenesis and angiogenesis, and improved cardiac remodeling.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Amado, L.C., Saliaris, A.P., Schuleri, K.H., St John, M., Xie, J.S., Cattaneo, S., Durand, D.J., Fitton, T., Kuang, J.Q., Stewart, G., et al., 2005. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc. Natl. Acad. Sci. USA, 102(32):11474–11479. [doi:10.1073/pnas.0504388102]
Amado, L.C., Schuleri, K.H., Saliaris, A.P., Boyle, A.J., Helm, R., Oskouei, B., Centola, M., Eneboe, V., Young, R., Lima, J.A., et al., 2006. Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapy. J. Am. Coll. Cardiol., 48(10):2116–2124. [doi:10.1016/j.jacc.2006.06.073]
Anversa, P., Kajstura, J., Leri, A., Bolli, R., 2006. Life and death of cardiac stem cells: a paradigm shift in cardiac biology. Circulation, 113(11):1451–1463. [doi:10.1161/CIRCULATIONAHA.105.595181]
Balsam, L.B., Wagers, A.J., Christensen, J.L., Kofidis, T., Weissman, I.L., Robbins, R.C., 2004. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature, 428(6983):668–673. [doi:10.1038/nature02460]
Caplan, A.I., Dennis, J.E., 2006. Mesenchymal stem cells as trophic mediators. J. Cell. Biochem., 98(5):1076–1084. [doi:10.1002/jcb.20886]
Chen, S.L., Fang, W.W., Ye, F., Liu, Y.H., Qian, J., Shan, S.J., Zhang, J.J., Chunhua, R.Z., Liao, L.M., Lin, S., et al., 2004. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am. J. Cardiol., 94(1):92–95. [doi:10.1016/j.amjcard.2004.03.034]
Dai, W., Hale, S.L., Martin, B.J., Kuang, J.Q., Dow, J.S., Wold, L.E., Kloner, R.A., 2005. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation, 112(2):214–223. [doi:10.1161/CIRCULATIONAHA.104.527937]
Davani, S., Marandin, A., Mersin, N., Royer, B., Kantelip, B., Herve, P., Etievent, J.P., Kantelip, J.P., 2003. Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model. Circulation, 108(Suppl. 1):II253–II258.
Hunt, S.A., 2005. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J. Am. Coll. Cardiol., 46(6):e1–82. [doi:10.1016/j.jacc.2005.08.022]
Kajstura, J., Urbanek, K., Rota, M., Bearzi, C., Hosoda, T., Bolli, R., Anversa, P., Leri, A., 2008. Cardiac stem cells and myocardial disease. J. Mol. Cell. Cardiol., 45(4): 505–513. [doi:10.1016/j.yjmcc.2008.05.025]
Murry, C.E., Soonpaa, M.H., Reinecke, H., Nakajima, H., Nakajima, H.O., Rubart, M., Pasumarthi, K.B., Virag, J.I., Bartelmez, S.H., Poppa, V., et al., 2004. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature, 428(6983):664–668. [doi:10.1038/nature02446]
Nagaya, N., Kangawa, K., Itoh, T., Iwase, T., Murakami, S., Miyahara, Y., Fujii, T., Uematsu, M., Ohgushi, H., Yamagishi, M., et al., 2005. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation, 112(8): 1128–1135. [doi:10.1161/CIRCULATIONAHA.104.500447]
Nakamura, T., Mizuno, S., Matsumoto, K., Sawa, Y., Matsuda, H., 2000. Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J. Clin. Invest., 106(12):1511–1519. [doi:10.1172/JCI10226]
Pedrotty, D.M., Niklason, L.E., 2003. Angiogenesis therapies for cardiovascular disease. Curr. Opin. Anaesthesiol., 16(1):3–9. [doi:10.1097/00001503-200302000-00002]
Sadat, S., Gehmert, S., Song, Y.H., Yen, Y., Bai, X., Gaiser, S., Klein, H., Alt, E., 2007. The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF. Biochem. Biophys. Res. Commun., 363(3):674–679. [doi:10.1016/j.bbrc.2007.09.058]
Tao, Z.W., Li, L.G., 2007. Cell therapy in congestive heart failure. J. Zhejiang Univ.-Sci. B, 8(9):647–660. [doi:10.1631/jzus.2007.B0647]
Tao, Z.W., Huang, Y.W., Xia, Q., Fu, J., Zhao, Z.H., Lu, X., Bruce, I.C., 2004. Early association of electrocardiogram alteration with infarct size and cardiac function after myocardial infarction. J. Zhejiang Univ. Sci., 5(4): 494–498. [doi:10.1631/jzus.2004.0494]
Tao, Z.W., Huang, Y.W., Xia, Q., Xu, Q.W., 2005. Combined effects of ramipril and angiotensin II receptor blocker TCV116 on rat congestive heart failure after myocardial infarction. Chin. Med. J. (Engl.), 118(2):146–154.
Urbanek, K., Rota, M., Cascapera, S., Bearzi, C., Nascimbene, A., De Angelis, A., Hosoda, T., Chimenti, S., Baker, M., Limana, F., et al., 2005. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ. Res., 97(7): 663–673. [doi:10.1161/01.RES.0000183733.53101.11]
Urbich, C., Aicher, A., Heeschen, C., Dernbach, E., Hofmann, W.K., Zeiher, A.M., Dimmeler, S., 2005. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J. Mol. Cell. Cardiol., 39(5):733–742. [doi:10.1016/j.yjmcc.2005.07.003]
Xiang, M.X., He, A.N., Wang, J.A., Gui, C., 2009. Protective paracrine effect of mesenchymal stem cells on cardiomyocytes. J. Zhejiang Univ-Sci. B, 10(8):619–624. [doi:10.1631/jzus.B0920153]
Author information
Authors and Affiliations
Corresponding author
Additional information
Project (No. 20060400200) supported by the China Postdoctoral Science Foundation
Rights and permissions
About this article
Cite this article
Tao, Zw., Li, Lg., Geng, Zh. et al. Growth factors induce the improved cardiac remodeling in autologous mesenchymal stem cell-implanted failing rat hearts. J. Zhejiang Univ. Sci. B 11, 238–248 (2010). https://doi.org/10.1631/jzus.B0900244
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1631/jzus.B0900244